H.R. No. 177

	R E S O L U T I O N
	WHEREAS, Bleeding disorders, including hemophilia and von
	Willebrand disease, are genetic disorders that prevent the blood of
	sufferers from clotting properly, leading to debilitating and
	potentially fatal bleeding episodes; and
	WHEREAS, About 20,000 people in the United States are
	estimated to be affected with hemophilia, which results from a
	missing or deficient protein needed for blood clotting; an X-linked
	recessive trait, hemophilia is primarily found in males; and
	WHEREAS, The most common bleeding disorder, von Willebrand
	disease, also results from a defective blood protein but is
	typically milder than hemophilia; it is believed to affect up to one
	percent of the U.S. population, and many individuals, particularly
	women, go undiagnosed; and
	WHEREAS, Bleeding disorders can vary greatly in severity,
	with the most serious cases of hemophilia carrying the risk of
	excessive bleeding from accidents and surgeries, in addition to
	long-term damage to organs, tissues, and joints from internal
	bleeding over time; in recent decades, new medical developments and
	donor screening measures have greatly improved the safety and
	effectiveness of treatments such as factor replacement therapy,
	which can help patients to live normal, healthy lives; and
	WHEREAS, In 2016, the National Hemophilia Foundation
	declared March as Bleeding Disorders Awareness Month; this
	initiative is supported by Texas-based groups such as the Texas
	Bleeding Disorders Coalition, which is encouraging residents to
	participate in the Red Tie Challenge to help start a conversation
	about inheritable bleeding disorders and to promote advocacy for
	people who are living with bleeding disorders all over the world;
	and
	WHEREAS, While science and medicine have advanced greatly in
	the treatment of bleeding disorders, increased public awareness is
	needed to help ease the heavy financial burden and improve the
	quality of life of patients, and Bleeding Disorders Awareness Month
	provides an opportune time to join together in support of these
	worthy goals; now, therefore, be it
	RESOLVED, That the House of Representatives of the 85th Texas
	Legislature hereby recognize March 2017 as Bleeding Disorders
	Awareness Month and urge all Texans to learn more about these
	conditions.
	Sheffield
	Straus Goldman Oliverson
	Allen Gonzales of Williamson Ortega
	Alonzo González of El Paso Paddie
	Alvarado Gooden Parker
	Anchia Guerra Paul
	Anderson of Dallas Guillen Perez
	Anderson of McLennan Gutierrez Phelan
	Arévalo Hefner Phillips
	Ashby Hernandez Pickett
	Bailes Herrero Price
	Bell Hinojosa Raney
	Bernal Holland Raymond
	Biedermann Howard Reynolds
	Blanco Huberty Rinaldi
	Bohac Hunter Roberts
	Bonnen of Brazoria Isaac Rodriguez of Bexar
	Bonnen of Galveston Israel Rodriguez of Travis
	Burkett Johnson of Dallas Romero, Jr.
	Burns Johnson of Harris Rose
	Burrows Kacal Sanford
	Button Keough Schaefer
	Cain King of Hemphill Schofield
	Canales King of Parker Schubert
	Capriglione King of Uvalde Shaheen
	Clardy Klick Sheffield
	Coleman Koop Shine
	Collier Krause Simmons
	Cook Kuempel Smithee
	Cortez Lambert Springer
	Cosper Landgraf Stephenson
	Craddick Lang Stickland
	Cyrier Larson Stucky
	Dale Laubenberg Swanson
	Darby Leach Thierry
	Davis of Dallas Longoria Thompson of Brazoria
	Davis of Harris Lozano Thompson of Harris
	Dean Lucio III Tinderholt
	Deshotel Martinez Turner
	Dukes Metcalf Uresti
	Dutton Meyer VanDeaver
	Elkins Miller Villalba
	Faircloth Minjarez Vo
	Fallon Moody Walle
	Farrar Morrison White
	Flynn Muñoz, Jr. Wilson
	Frank Murphy Workman
	Frullo Murr Wray
	Geren Neave Wu
	Gervin-Hawkins Nevárez Zedler
	Giddings Oliveira Zerwas
	______________________________
	Speaker of the House
	I certify that H.R. No. 177 was adopted by the House on January
	25, 2017, by a non-record vote.
	______________________________
	Chief Clerk of the House